IDNA vs. FFTY ETF Comparison

Comparison of iShares Genomics Immunology and Healthcare ETF (IDNA) to Innovator IBD 50 Fund ETF (FFTY)
IDNA

iShares Genomics Immunology and Healthcare ETF

IDNA Description

The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.

Grade (RS Rating)

Last Trade

$24.49

Average Daily Volume

28,823

Number of Holdings *

33

* may have additional holdings in another (foreign) market
FFTY

Innovator IBD 50 Fund ETF

FFTY Description The investment seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in companies included in the IBD® 50 Index. It is actively managed. Under normal circumstances, the fund will invest in a portfolio of U.S.-listed, exchange-traded equities. FFTY picks 50 leading growth companies that trade on US exchanges, potentially including ADRs. After screening out securities with extreme recent price movements, the universe is ranked by a composite of 11 different fundamental and technical metrics. The top 50 stocks are weighted in tiers, with more weight given to higher-ranking companies. Components of the index are reviewed on a weekly basis. Based on market-wide technical signals, FFTY may substitute half of its equity portfolio with Treasury bills. The index will remain half equity, half T-bills until a reversal signal occurs. Its worth noting that the funds high-turnover strategy could lead to poor tracking and/or taxable capital gains payouts.

Grade (RS Rating)

Last Trade

$26.58

Average Daily Volume

124,648

Number of Holdings *

50

* may have additional holdings in another (foreign) market
Performance
Period IDNA FFTY
30 Days -1.88% 2.35%
60 Days 3.05% 8.18%
90 Days 7.11% -5.04%
12 Months 26.47% 23.10%
2 Overlapping Holdings
Symbol Grade Weight in IDNA Weight in FFTY Overlap
SRPT F 4.06% 0.96% 0.96%
TWST D 2.94% 1.05% 1.05%
IDNA Overweight 31 Positions Relative to FFTY
Symbol Grade Weight
GILD A 5.15%
EXEL B 4.81%
INCY B 4.42%
RVMD B 4.36%
REGN D 4.16%
ACLX C 3.78%
MRK F 3.47%
GERN D 2.49%
SWTX F 2.38%
IOVA F 2.32%
BEAM F 2.16%
LGND D 1.96%
NVAX C 1.82%
MRNA F 1.7%
BCRX D 1.68%
DVAX D 1.58%
NRIX D 1.48%
BPMC F 1.37%
CRSP F 0.94%
RCUS F 0.83%
VIR F 0.73%
IBRX F 0.67%
ARCT D 0.6%
FDMT F 0.53%
NTLA F 0.49%
OABI F 0.45%
EDIT F 0.32%
XNCR D 0.31%
DNA F 0.3%
QURE F 0.27%
MGNX F 0.2%
IDNA Underweight 48 Positions Relative to FFTY
Symbol Grade Weight
ARM C -3.85%
CAMT F -3.71%
NVDA C -3.7%
MMYT D -3.63%
ANET A -3.54%
CLS B -3.49%
NSSC F -3.46%
CRWD D -3.46%
TMDX D -3.43%
HIMS B -3.37%
RCL C -3.09%
ALNY C -3.05%
GOOGL B -3.02%
BWIN B -3.0%
NFLX A -2.99%
ELF F -2.99%
NVO F -2.91%
STEP A -2.87%
WING B -2.78%
CMRE B -2.71%
TGTX C -2.15%
PLTR A -2.09%
PSTG F -2.07%
VITL B -2.06%
HUT D -2.02%
MNDY C -1.98%
FN B -1.96%
NTRA A -1.95%
BROS F -1.95%
FRPT C -1.93%
MIRM D -1.07%
UTHR C -1.01%
APPF C -0.99%
KKR A -0.98%
IBKR A -0.97%
AX D -0.97%
TOST C -0.95%
NOW C -0.93%
ONTO B -0.52%
AVGO C -0.52%
C B -0.51%
HEI A -0.5%
CTAS B -0.5%
AXP A -0.5%
SNPS F -0.49%
RYAN A -0.49%
KSPI F -0.49%
ASND C -0.49%
Compare ETFs